We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-12.48%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$13.6M
(+1.3%)
Cap. Flow
+$175M
Cap. Flow
% of AUM
16.88%
Top 10 Holdings %
Top 10 Hldgs %
6.41%
Holding
1,241
New
361
Increased
285
Reduced
228
Closed
365
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AEGN
Aegion Corp
AEGN
|
+$6.95M |
| 2 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
+$6.17M |
| 3 |
MTOR
MERITOR, Inc.
MTOR
|
+$6.08M |
| 4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$5.62M |
| 5 |
KRA
Kraton Corporation
KRA
|
+$5.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NTUS
Natus Medical Inc
NTUS
|
+$5.73M |
| 2 |
Enanta Pharmaceuticals
ENTA
|
+$5.45M |
| 3 |
UNTD
UNITED ONLINE INC COM NEW
UNTD
|
+$5.41M |
| 4 |
JIVE
Jive Software, Inc.
JIVE
|
+$5.4M |
| 5 |
Merit Medical Systems
MMSI
|
+$5.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Industrials | 14.63% |
| 3 | Technology | 13.41% |
| 4 | Consumer Discretionary | 11.65% |
| 5 | Financials | 6.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Digi International
DGII
$2.55B
| $700K | 0.07% |
59,397
+31,710
| +115% | +$323K |
|
|
NUTR
427
DELISTED
Nutraceutical International Co
NUTR
| $699K | 0.07% |
+29,610
| New | +$709K |
|
428
Consumer Portfolio Services
CPSS
$201M
| $692K | 0.07% |
138,928
-16,524
| -11% | -$94.8K |
|
429
Pegasystems
PEGA
$4.7B
| $692K | 0.07% |
+56,234
| New | +$696K |
|
430
Hackett Group
HCKT
$255M
| $689K | 0.07% |
+50,105
| New | +$687K |
|
|
ITG
431
DELISTED
Investment Technology Group Inc
ITG
| $689K | 0.07% |
51,634
-7,533
| -13% | -$140K |
|
|
AOI
432
DELISTED
Alliance One International
AOI
| $682K | 0.07% |
+33,456
| New | +$757K |
|
|
AAIC
433
DELISTED
Arlington Asset Investment Corp.
AAIC
| $678K | 0.07% |
48,266
+14,133
| +41% | +$250K |
|
434
The GEO Group
GEO
$4.13B
| $677K | 0.07% |
34,124
+3,633
| +12% | +$80.3K |
|
|
GTY
435
Getty Realty Corp
GTY
$2.12B
| $677K | 0.07% |
+43,399
| New | +$696K |
|
|
SAAS
436
DELISTED
inContact, Inc.
SAAS
| $675K | 0.07% |
+89,903
| New | +$742K |
|
437
Enova International
ENVA
$6.27B
| $671K | 0.06% |
65,636
-41,322
| -39% | -$595K |
|
|
IQNT
438
DELISTED
Inteliquent, Inc.
IQNT
| $670K | 0.06% |
30,012
-94,818
| -76% | -$1.8M |
|
|
CUTR
439
DELISTED
Cutera, Inc.
CUTR
| $669K | 0.06% |
51,185
+18,047
| +54% | +$268K |
|
|
KTWO
440
DELISTED
K2M Group Holdings, Inc
KTWO
| $669K | 0.06% |
+35,985
| New | +$787K |
|
441
Wolverine World Wide
WWW
$1.56B
| $668K | 0.06% |
+30,864
| New | +$840K |
|
|
BFX
442
DELISTED
BowFlex Inc.
BFX
| $668K | 0.06% |
44,562
+20,497
| +85% | +$368K |
|
443
Ameris Bancorp
ABCB
$5.77B
| $667K | 0.06% |
23,205
-51,413
| -69% | -$1.4M |
|
|
RDC
444
DELISTED
Rowan Companies Plc
RDC
| $665K | 0.06% |
41,187
-11,419
| -22% | -$199K |
|
445
Neogen
NEOG
$2.03B
| $658K | 0.06% |
39,011
+10,507
| +37% | +$207K |
|
446
Achieve Life Sciences
ACHV
$634M
| $649K | 0.06% |
132
+42
| +47% | +$253K |
|
447
Fate Therapeutics
FATE
$283M
| $646K | 0.06% |
121,151
+39,354
| +48% | +$269K |
|
|
RUTH
448
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $646K | 0.06% |
39,770
-109,257
| -73% | -$1.79M |
|
449
Ennis
EBF
$550M
| $641K | 0.06% |
36,914
-120,043
| -76% | -$2.02M |
|
450
Madrigal Pharmaceuticals
MDGL
$12.7B
| $639K | 0.06% |
10,496
+9,105
| +655% | +$657K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q3 2015 Portfolio in Review
As of Q3 2015, TFS Capital held 1,241 positions worth $1.04B, up 1.3% from $1.02B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
TFS Capital deployed $175M of net new capital in Q3 2015, opening 361 new positions and adding to 285 existing holdings. Its largest new stake was Aegion Corp: 384,454 shares worth $6.34M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Merit Medical Systems, an estimated $5.27M trimmed.
- TFS Capital's largest Q3 2015 buy was Aegion Corp: 384,454 shares worth $6.34M.
- TFS Capital added most to Pernix Therapeutics Holdings, Inc. in Q3 2015, an estimated $6.17M increase.
- TFS Capital's biggest Q3 2015 reduction was Merit Medical Systems, cutting an estimated $5.27M.
- TFS Capital fully exited Natus Medical Inc in Q3 2015, selling an estimated $5.73M.
- TFS Capital's ten largest holdings make up 6.4% of its $1.04B portfolio in Q3 2015.
- TFS Capital opened 361 new positions and closed 365 in Q3 2015.
- TFS Capital's portfolio value rose 1.3% quarter-over-quarter to $1.04B.
Based on TFS Capital's 13F filing for Q3 2015, filed 3 Nov 2015.